ID   MSR3-mel
AC   CVCL_VV18
SY   AUMA
DR   Wikidata; Q95991314
RX   PubMed=10363990;
RX   PubMed=11668505;
CC   HLA typing: A*01:01,11:01; B*37:01,52:01:01:01; C*06:02,12:02 (PubMed=11668505).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VV17 ! MSR3-EBV
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
RX   PubMed=10363990;
RA   Tanzarella S., Russo V., Lionello I., Dalerba P., Rigatti D.,
RA   Bordignon C., Traversari C.;
RT   "Identification of a promiscuous T-cell epitope encoded by multiple
RT   members of the MAGE family.";
RL   Cancer Res. 59:2668-2674(1999).
//
RX   PubMed=11668505; DOI=10.1002/ijc.1452;
RA   Serrano A., Tanzarella S., Lionello I., Mendez R., Traversari C.,
RA   Ruiz-Cabello Osuna F., Garrido F.;
RT   "Rexpression of HLA class I antigens and restoration of
RT   antigen-specific CTL response in melanoma cells following
RT   5-aza-2'-deoxycytidine treatment.";
RL   Int. J. Cancer 94:243-251(2001).
//